chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Diabetes mellitus, Diarrhoea, Drain placement, Eructation
Clinical narrative: Patient hospitalized within a month of receiving J&J vaccine (symptom onset reported two days after administration) INCARCERATED VENTRAL HERNIA; SMALL BOWEL OBSTRUCTION Received COVID vaccine (J&J) - 1.7.22 Symptoms started - 1.9.22 (diarrhea, body-aches, fatigue, vomiting, pain in stomach, wheezing)  - reported 1.18.22 Seen by PCP (1.19.22) - Fatigue, diarrhea, vomiting 1.9.22; body-aches, sneezing, no exposures - ill, nauseous, queasy, achy, miss work - DX: URI, obtain CXR (-), and COVID/flu swab (-).  started doxycycline for 'sinusitis'; prescribed zofran; albuterol for wheeze.  Labs - mild increase WBC, not peeing as much - abnormal CMP (SCR increased from 0.82 in 2018 - to 2.65; potassium 5.1; BUN 98; eGFR 25; triglycerides 229; hgb A1c - 7.1; glucose 143; BNP normal) 1.26.22 - PCP office visit - diagnosed with diabetes mellitus - -will start on metformin 500 mg bid (reviewed this may cause diarrhea) -monofilament and urine microalbumin completed for 2022 -positive for urine microalbumin but will hold off on restarting lisinopril at this time due to renal insufficiency -will re-evaluate if renal function is improving -will refer to diabetes education -will refer for diabetic eye exam -reviewed long term complications of uncontrolled diabetes including kidney failure, blindness, heart attack, and stroke -follow up in 3 months 2.4.22 - Office visit - PCP - abdominal pain. (reported to Nurse Triage on 2.3.22 - continued diarrhea, vomiting, has been seen multiple times; now on inhaler and meds for DM; wheezing; significant abdominal pain)  Hospitalized 2.7.22: Assessment & Plan: 60 y/o M with ventral incarcerated hernia. Given tenderness and obstruction, we are obligated to explore his abdomen.   HPI: Patient is a 60 y.o. male with history of primary UHR in 2018 for incarcerated hernia, EtOH abuse, HTN, and T2DM who presents today with one week of obstructive symptoms related to his ventral hernia. He says starting one week ago he noticed an abdominal bulge that was painful and with associated nausea and emesis. He also endorses belching. His last BM was this morning but was very small. He has not passed flatus in several days. He says he has been "living on slimfast, powerades."   Progress Note from 2.10.22:  ASSESSMENT / PLAN:  Assessment: Patient is a 60 y.o. male with  history significant for UHR who presents with incarcerated ventral hernia and associated SBO and is now s/p ventral hernia repair with JP placement in subQ space 2/8/22.   Plan: SBO 2/2 ventral hernia - S/p open repair of hernia in OR 2/8 - Diet: CLD, tolerating. Advance to general - Keep JP drain for now. Will pull once < 30 cc for two consecutive days. - NGT self-pulled 2/9 x2 - Analgesic regimen: sch tylenol/robaxin, prn oxy              - denied TAP blocks - Antiemetic regimen: PRN IV Zofran, PRN Compazine - Will initiate gentle bowel regimen
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Glomerular filtration rate decreased, Glycosylated haemoglobin increased, Hypophagia, Impaired work ability
Clinical narrative: Patient hospitalized within a month of receiving J&J vaccine (symptom onset reported two days after administration) INCARCERATED VENTRAL HERNIA; SMALL BOWEL OBSTRUCTION Received COVID vaccine (J&J) - 1.7.22 Symptoms started - 1.9.22 (diarrhea, body-aches, fatigue, vomiting, pain in stomach, wheezing)  - reported 1.18.22 Seen by PCP (1.19.22) - Fatigue, diarrhea, vomiting 1.9.22; body-aches, sneezing, no exposures - ill, nauseous, queasy, achy, miss work - DX: URI, obtain CXR (-), and COVID/flu swab (-).  started doxycycline for 'sinusitis'; prescribed zofran; albuterol for wheeze.  Labs - mild increase WBC, not peeing as much - abnormal CMP (SCR increased from 0.82 in 2018 - to 2.65; potassium 5.1; BUN 98; eGFR 25; triglycerides 229; hgb A1c - 7.1; glucose 143; BNP normal) 1.26.22 - PCP office visit - diagnosed with diabetes mellitus - -will start on metformin 500 mg bid (reviewed this may cause diarrhea) -monofilament and urine microalbumin completed for 2022 -positive for urine microalbumin but will hold off on restarting lisinopril at this time due to renal insufficiency -will re-evaluate if renal function is improving -will refer to diabetes education -will refer for diabetic eye exam -reviewed long term complications of uncontrolled diabetes including kidney failure, blindness, heart attack, and stroke -follow up in 3 months 2.4.22 - Office visit - PCP - abdominal pain. (reported to Nurse Triage on 2.3.22 - continued diarrhea, vomiting, has been seen multiple times; now on inhaler and meds for DM; wheezing; significant abdominal pain)  Hospitalized 2.7.22: Assessment & Plan: 60 y/o M with ventral incarcerated hernia. Given tenderness and obstruction, we are obligated to explore his abdomen.   HPI: Patient is a 60 y.o. male with history of primary UHR in 2018 for incarcerated hernia, EtOH abuse, HTN, and T2DM who presents today with one week of obstructive symptoms related to his ventral hernia. He says starting one week ago he noticed an abdominal bulge that was painful and with associated nausea and emesis. He also endorses belching. His last BM was this morning but was very small. He has not passed flatus in several days. He says he has been "living on slimfast, powerades."   Progress Note from 2.10.22:  ASSESSMENT / PLAN:  Assessment: Patient is a 60 y.o. male with  history significant for UHR who presents with incarcerated ventral hernia and associated SBO and is now s/p ventral hernia repair with JP placement in subQ space 2/8/22.   Plan: SBO 2/2 ventral hernia - S/p open repair of hernia in OR 2/8 - Diet: CLD, tolerating. Advance to general - Keep JP drain for now. Will pull once < 30 cc for two consecutive days. - NGT self-pulled 2/9 x2 - Analgesic regimen: sch tylenol/robaxin, prn oxy              - denied TAP blocks - Antiemetic regimen: PRN IV Zofran, PRN Compazine - Will initiate gentle bowel regimen
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Incarcerated hernia, Intestinal strangulation, Malaise, Metabolic function test abnormal, Monofilament pressure perception test
Clinical narrative: Patient hospitalized within a month of receiving J&J vaccine (symptom onset reported two days after administration) INCARCERATED VENTRAL HERNIA; SMALL BOWEL OBSTRUCTION Received COVID vaccine (J&J) - 1.7.22 Symptoms started - 1.9.22 (diarrhea, body-aches, fatigue, vomiting, pain in stomach, wheezing)  - reported 1.18.22 Seen by PCP (1.19.22) - Fatigue, diarrhea, vomiting 1.9.22; body-aches, sneezing, no exposures - ill, nauseous, queasy, achy, miss work - DX: URI, obtain CXR (-), and COVID/flu swab (-).  started doxycycline for 'sinusitis'; prescribed zofran; albuterol for wheeze.  Labs - mild increase WBC, not peeing as much - abnormal CMP (SCR increased from 0.82 in 2018 - to 2.65; potassium 5.1; BUN 98; eGFR 25; triglycerides 229; hgb A1c - 7.1; glucose 143; BNP normal) 1.26.22 - PCP office visit - diagnosed with diabetes mellitus - -will start on metformin 500 mg bid (reviewed this may cause diarrhea) -monofilament and urine microalbumin completed for 2022 -positive for urine microalbumin but will hold off on restarting lisinopril at this time due to renal insufficiency -will re-evaluate if renal function is improving -will refer to diabetes education -will refer for diabetic eye exam -reviewed long term complications of uncontrolled diabetes including kidney failure, blindness, heart attack, and stroke -follow up in 3 months 2.4.22 - Office visit - PCP - abdominal pain. (reported to Nurse Triage on 2.3.22 - continued diarrhea, vomiting, has been seen multiple times; now on inhaler and meds for DM; wheezing; significant abdominal pain)  Hospitalized 2.7.22: Assessment & Plan: 60 y/o M with ventral incarcerated hernia. Given tenderness and obstruction, we are obligated to explore his abdomen.   HPI: Patient is a 60 y.o. male with history of primary UHR in 2018 for incarcerated hernia, EtOH abuse, HTN, and T2DM who presents today with one week of obstructive symptoms related to his ventral hernia. He says starting one week ago he noticed an abdominal bulge that was painful and with associated nausea and emesis. He also endorses belching. His last BM was this morning but was very small. He has not passed flatus in several days. He says he has been "living on slimfast, powerades."   Progress Note from 2.10.22:  ASSESSMENT / PLAN:  Assessment: Patient is a 60 y.o. male with  history significant for UHR who presents with incarcerated ventral hernia and associated SBO and is now s/p ventral hernia repair with JP placement in subQ space 2/8/22.   Plan: SBO 2/2 ventral hernia - S/p open repair of hernia in OR 2/8 - Diet: CLD, tolerating. Advance to general - Keep JP drain for now. Will pull once < 30 cc for two consecutive days. - NGT self-pulled 2/9 x2 - Analgesic regimen: sch tylenol/robaxin, prn oxy              - denied TAP blocks - Antiemetic regimen: PRN IV Zofran, PRN Compazine - Will initiate gentle bowel regimen
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, SARS-CoV-2 test negative, Scan with contrast abnormal, Sinusitis
Clinical narrative: Patient hospitalized within a month of receiving J&J vaccine (symptom onset reported two days after administration) INCARCERATED VENTRAL HERNIA; SMALL BOWEL OBSTRUCTION Received COVID vaccine (J&J) - 1.7.22 Symptoms started - 1.9.22 (diarrhea, body-aches, fatigue, vomiting, pain in stomach, wheezing)  - reported 1.18.22 Seen by PCP (1.19.22) - Fatigue, diarrhea, vomiting 1.9.22; body-aches, sneezing, no exposures - ill, nauseous, queasy, achy, miss work - DX: URI, obtain CXR (-), and COVID/flu swab (-).  started doxycycline for 'sinusitis'; prescribed zofran; albuterol for wheeze.  Labs - mild increase WBC, not peeing as much - abnormal CMP (SCR increased from 0.82 in 2018 - to 2.65; potassium 5.1; BUN 98; eGFR 25; triglycerides 229; hgb A1c - 7.1; glucose 143; BNP normal) 1.26.22 - PCP office visit - diagnosed with diabetes mellitus - -will start on metformin 500 mg bid (reviewed this may cause diarrhea) -monofilament and urine microalbumin completed for 2022 -positive for urine microalbumin but will hold off on restarting lisinopril at this time due to renal insufficiency -will re-evaluate if renal function is improving -will refer to diabetes education -will refer for diabetic eye exam -reviewed long term complications of uncontrolled diabetes including kidney failure, blindness, heart attack, and stroke -follow up in 3 months 2.4.22 - Office visit - PCP - abdominal pain. (reported to Nurse Triage on 2.3.22 - continued diarrhea, vomiting, has been seen multiple times; now on inhaler and meds for DM; wheezing; significant abdominal pain)  Hospitalized 2.7.22: Assessment & Plan: 60 y/o M with ventral incarcerated hernia. Given tenderness and obstruction, we are obligated to explore his abdomen.   HPI: Patient is a 60 y.o. male with history of primary UHR in 2018 for incarcerated hernia, EtOH abuse, HTN, and T2DM who presents today with one week of obstructive symptoms related to his ventral hernia. He says starting one week ago he noticed an abdominal bulge that was painful and with associated nausea and emesis. He also endorses belching. His last BM was this morning but was very small. He has not passed flatus in several days. He says he has been "living on slimfast, powerades."   Progress Note from 2.10.22:  ASSESSMENT / PLAN:  Assessment: Patient is a 60 y.o. male with  history significant for UHR who presents with incarcerated ventral hernia and associated SBO and is now s/p ventral hernia repair with JP placement in subQ space 2/8/22.   Plan: SBO 2/2 ventral hernia - S/p open repair of hernia in OR 2/8 - Diet: CLD, tolerating. Advance to general - Keep JP drain for now. Will pull once < 30 cc for two consecutive days. - NGT self-pulled 2/9 x2 - Analgesic regimen: sch tylenol/robaxin, prn oxy              - denied TAP blocks - Antiemetic regimen: PRN IV Zofran, PRN Compazine - Will initiate gentle bowel regimen
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Small intestinal obstruction, Sneezing, Tenderness, Upper respiratory tract infection, Urine output decreased
Clinical narrative: Patient hospitalized within a month of receiving J&J vaccine (symptom onset reported two days after administration) INCARCERATED VENTRAL HERNIA; SMALL BOWEL OBSTRUCTION Received COVID vaccine (J&J) - 1.7.22 Symptoms started - 1.9.22 (diarrhea, body-aches, fatigue, vomiting, pain in stomach, wheezing)  - reported 1.18.22 Seen by PCP (1.19.22) - Fatigue, diarrhea, vomiting 1.9.22; body-aches, sneezing, no exposures - ill, nauseous, queasy, achy, miss work - DX: URI, obtain CXR (-), and COVID/flu swab (-).  started doxycycline for 'sinusitis'; prescribed zofran; albuterol for wheeze.  Labs - mild increase WBC, not peeing as much - abnormal CMP (SCR increased from 0.82 in 2018 - to 2.65; potassium 5.1; BUN 98; eGFR 25; triglycerides 229; hgb A1c - 7.1; glucose 143; BNP normal) 1.26.22 - PCP office visit - diagnosed with diabetes mellitus - -will start on metformin 500 mg bid (reviewed this may cause diarrhea) -monofilament and urine microalbumin completed for 2022 -positive for urine microalbumin but will hold off on restarting lisinopril at this time due to renal insufficiency -will re-evaluate if renal function is improving -will refer to diabetes education -will refer for diabetic eye exam -reviewed long term complications of uncontrolled diabetes including kidney failure, blindness, heart attack, and stroke -follow up in 3 months 2.4.22 - Office visit - PCP - abdominal pain. (reported to Nurse Triage on 2.3.22 - continued diarrhea, vomiting, has been seen multiple times; now on inhaler and meds for DM; wheezing; significant abdominal pain)  Hospitalized 2.7.22: Assessment & Plan: 60 y/o M with ventral incarcerated hernia. Given tenderness and obstruction, we are obligated to explore his abdomen.   HPI: Patient is a 60 y.o. male with history of primary UHR in 2018 for incarcerated hernia, EtOH abuse, HTN, and T2DM who presents today with one week of obstructive symptoms related to his ventral hernia. He says starting one week ago he noticed an abdominal bulge that was painful and with associated nausea and emesis. He also endorses belching. His last BM was this morning but was very small. He has not passed flatus in several days. He says he has been "living on slimfast, powerades."   Progress Note from 2.10.22:  ASSESSMENT / PLAN:  Assessment: Patient is a 60 y.o. male with  history significant for UHR who presents with incarcerated ventral hernia and associated SBO and is now s/p ventral hernia repair with JP placement in subQ space 2/8/22.   Plan: SBO 2/2 ventral hernia - S/p open repair of hernia in OR 2/8 - Diet: CLD, tolerating. Advance to general - Keep JP drain for now. Will pull once < 30 cc for two consecutive days. - NGT self-pulled 2/9 x2 - Analgesic regimen: sch tylenol/robaxin, prn oxy              - denied TAP blocks - Antiemetic regimen: PRN IV Zofran, PRN Compazine - Will initiate gentle bowel regimen
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting, Wheezing, White blood cell count increased
Clinical narrative: Patient hospitalized within a month of receiving J&J vaccine (symptom onset reported two days after administration) INCARCERATED VENTRAL HERNIA; SMALL BOWEL OBSTRUCTION Received COVID vaccine (J&J) - 1.7.22 Symptoms started - 1.9.22 (diarrhea, body-aches, fatigue, vomiting, pain in stomach, wheezing)  - reported 1.18.22 Seen by PCP (1.19.22) - Fatigue, diarrhea, vomiting 1.9.22; body-aches, sneezing, no exposures - ill, nauseous, queasy, achy, miss work - DX: URI, obtain CXR (-), and COVID/flu swab (-).  started doxycycline for 'sinusitis'; prescribed zofran; albuterol for wheeze.  Labs - mild increase WBC, not peeing as much - abnormal CMP (SCR increased from 0.82 in 2018 - to 2.65; potassium 5.1; BUN 98; eGFR 25; triglycerides 229; hgb A1c - 7.1; glucose 143; BNP normal) 1.26.22 - PCP office visit - diagnosed with diabetes mellitus - -will start on metformin 500 mg bid (reviewed this may cause diarrhea) -monofilament and urine microalbumin completed for 2022 -positive for urine microalbumin but will hold off on restarting lisinopril at this time due to renal insufficiency -will re-evaluate if renal function is improving -will refer to diabetes education -will refer for diabetic eye exam -reviewed long term complications of uncontrolled diabetes including kidney failure, blindness, heart attack, and stroke -follow up in 3 months 2.4.22 - Office visit - PCP - abdominal pain. (reported to Nurse Triage on 2.3.22 - continued diarrhea, vomiting, has been seen multiple times; now on inhaler and meds for DM; wheezing; significant abdominal pain)  Hospitalized 2.7.22: Assessment & Plan: 60 y/o M with ventral incarcerated hernia. Given tenderness and obstruction, we are obligated to explore his abdomen.   HPI: Patient is a 60 y.o. male with history of primary UHR in 2018 for incarcerated hernia, EtOH abuse, HTN, and T2DM who presents today with one week of obstructive symptoms related to his ventral hernia. He says starting one week ago he noticed an abdominal bulge that was painful and with associated nausea and emesis. He also endorses belching. His last BM was this morning but was very small. He has not passed flatus in several days. He says he has been "living on slimfast, powerades."   Progress Note from 2.10.22:  ASSESSMENT / PLAN:  Assessment: Patient is a 60 y.o. male with  history significant for UHR who presents with incarcerated ventral hernia and associated SBO and is now s/p ventral hernia repair with JP placement in subQ space 2/8/22.   Plan: SBO 2/2 ventral hernia - S/p open repair of hernia in OR 2/8 - Diet: CLD, tolerating. Advance to general - Keep JP drain for now. Will pull once < 30 cc for two consecutive days. - NGT self-pulled 2/9 x2 - Analgesic regimen: sch tylenol/robaxin, prn oxy              - denied TAP blocks - Antiemetic regimen: PRN IV Zofran, PRN Compazine - Will initiate gentle bowel regimen
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive COVID-19.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased, Oropharyngeal pain, Product administered to patient of inappropriate age
Clinical narrative: Patient was age 16 years when received Moderna vaccine, which is not recommended for persons under the age of 18.  Mother states she spoke with provider about this, and he told her "I think we are close enough it will be ok". Mother allowed patient to receive vaccine. For the following week patient c/o shortness of breath, Rapid heart rate, and sore throat. Mother brought patient back into clinic and was seen by a different provider, and was given a antibiotic therapy.  Mother states after finishing the antibiotic, patient recovered well.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive COVID-19.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood pressure increased, COVID-19, Death, Haemoglobin decreased
Clinical narrative: Patient died as a result of COVID 19
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, SARS-CoV-2 test, Troponin increased, White blood cell count decreased
Clinical narrative: Patient died as a result of COVID 19
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive COVID-19.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Urticaria
Clinical narrative: Severe hives, headache, chills, fever.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Death, Dyspnoea
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/26/21 and 3/26/21. Admitted to ED on 1/21/22 from outside rehab facility where she was dx'd w/COVID PNA x1 week, c/o dyspnea and hypoxia. Was on 2L of O2 at rehab which increased to need of 6L. Admitted to floor for acute on chronic resp failure 2/2 Covid PNA. Hypoxemia worsened on max HFNC during admission requiring intubation on 1/22/22 c/b septic shock transferred to ICU, extubated on 1/28/22, and reintubated on 1/29/22. Transitioned to comfort care/DNAR. Treated with dexamethasone, cefepime vancomycin, zosyn. Expired 2/06/22.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Hypoxia, Intensive care, SARS-CoV-2 test positive, Septic shock
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/26/21 and 3/26/21. Admitted to ED on 1/21/22 from outside rehab facility where she was dx'd w/COVID PNA x1 week, c/o dyspnea and hypoxia. Was on 2L of O2 at rehab which increased to need of 6L. Admitted to floor for acute on chronic resp failure 2/2 Covid PNA. Hypoxemia worsened on max HFNC during admission requiring intubation on 1/22/22 c/b septic shock transferred to ICU, extubated on 1/28/22, and reintubated on 1/29/22. Transitioned to comfort care/DNAR. Treated with dexamethasone, cefepime vancomycin, zosyn. Expired 2/06/22.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac flutter, Chest pain, Condition aggravated, Interchange of vaccine products, Limb discomfort
Clinical narrative: Outside of the normal reactions (lymph node swelling, arm discomfort), I also felt Heart fluttering, and had blurred vision evening of the booster. I felt mild heart fluttering after first 2 vaccines as well which were Moderna, but it was very mild. It was worse after booster, as I felt some heart fluttering / chest pain the day of the booster and the following day as well.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vision blurred
Clinical narrative: Outside of the normal reactions (lymph node swelling, arm discomfort), I also felt Heart fluttering, and had blurred vision evening of the booster. I felt mild heart fluttering after first 2 vaccines as well which were Moderna, but it was very mild. It was worse after booster, as I felt some heart fluttering / chest pain the day of the booster and the following day as well.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous, Swelling
Clinical narrative: My son received his first Covid vaccination on  1/7/22. On 1/16/22 he was noted to have bright red, painful rashes behind both knees. On 1/28/22 he received his second Covid vaccination. He now is dealing with swollen, red and painful rashes behind both knees and now both hands and all fingers.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac flutter, Electrocardiogram normal, Headache, Muscle spasms, Palpitations
Clinical narrative: On 01/27/2022 at approximately 06:45pm, patient called the pharmacy to report a side effect she believes is a result from the Janssen J&J Vaccine that was administered in her left deltoid on 12/09/2021. She stated about 10 days after receiving the vaccination she noticed a "butterfly feeling" in the right side of her chest. She reports it feels like a flutter/muscle spasm. She does not have a history of any heart condition (e.g. hypertension, heart murmur, or heart palpitations). She contacted her PCP on 01/26/2022 who scheduled an EKG for her on 02/04/2022 and told her to report the symptoms to the pharmacy. Patient also reports a headache occurring after the vaccination and the day after the vaccine was administered.  *** Update 02/10/2022 09:48am *** I spoke with staff at PCP's office regarding the EKG from 02/04/2022. Staff stated the patient is okay, she only had some palpitations and will be monitored by the office.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Death, Diarrhoea haemorrhagic, Dyspnoea
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/16/21 and 3/02/21. Presented to ED on 1/21/22 with bloody diarrhea and symptomatic of Covid-19. Dx'ed as Covid + 1/12/22, given course of remdesivir and dexamethasone, discharged with dexamethasone and azithromycin. Admitted for acute hypoxic resp failure, pt was placed on HFNC. Bloody diarrhea resolved but dypsnea and lung opacities worsened. Pt refused intubation and was transitioned to comfort care/DNAR. Treated with dexamethasone, remdesivir, rocephin, and doxycycline. Patient expired 2/05/22.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Lung opacity, Malaise, SARS-CoV-2 test positive
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 1/16/21 and 3/02/21. Presented to ED on 1/21/22 with bloody diarrhea and symptomatic of Covid-19. Dx'ed as Covid + 1/12/22, given course of remdesivir and dexamethasone, discharged with dexamethasone and azithromycin. Admitted for acute hypoxic resp failure, pt was placed on HFNC. Bloody diarrhea resolved but dypsnea and lung opacities worsened. Pt refused intubation and was transitioned to comfort care/DNAR. Treated with dexamethasone, remdesivir, rocephin, and doxycycline. Patient expired 2/05/22.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure, COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer-BioNTech Vaccines on 2/26/2021 and 3/19/2021. Patient's wife reported patient tested positive for COVID on 1/24/2022. Admitted for NSTEMI and acute hypoxic respiratory failure 2/2 COVID-19 infection. Patient received: vitamin C and zinc. Patient's respiratory status continued to decompensate and patient was transitioned to DNR/AND. Patient expired 2/3/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure, Anticoagulant therapy, COVID-19, COVID-19 pneumonia
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer-BioNTech Vaccines on 3/5/2021 and 3/25/2021. Presented from nursing home, admitted for acute hypoxemic respiratory failure due to COVID-19 PNA, lactic acidosis and NSTEMI. Received: oxygen supplementation, dexamethasone, antibiotics, and heparin. Patient had bloody bowel movements, hypotension, and respiratory status decline. Suffered cardiac arrest without ROSC. Expired on 2/4/2022 at 0458.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Death, Haematochezia, Hypotension, Lactic acidosis
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer-BioNTech Vaccines on 3/5/2021 and 3/25/2021. Presented from nursing home, admitted for acute hypoxemic respiratory failure due to COVID-19 PNA, lactic acidosis and NSTEMI. Received: oxygen supplementation, dexamethasone, antibiotics, and heparin. Patient had bloody bowel movements, hypotension, and respiratory status decline. Suffered cardiac arrest without ROSC. Expired on 2/4/2022 at 0458.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory disorder, SARS-CoV-2 test positive
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer-BioNTech Vaccines on 3/5/2021 and 3/25/2021. Presented from nursing home, admitted for acute hypoxemic respiratory failure due to COVID-19 PNA, lactic acidosis and NSTEMI. Received: oxygen supplementation, dexamethasone, antibiotics, and heparin. Patient had bloody bowel movements, hypotension, and respiratory status decline. Suffered cardiac arrest without ROSC. Expired on 2/4/2022 at 0458.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Adverse event, Anembryonic gestation, Exposure during pregnancy, Pruritus
Clinical narrative: On the onset of the adverse event (1/5/2021) I experienced full body hives and itching. At the same time of the adverse event I was experiencing a miscarriage (blighted ovum). Even after the miscarriage was completed, I continued to experience the persistent hives and itching and was diagnosed with chronic urticaria. Prior to receiving the COVID booster shot, I had never had any allergic reactions to food, vaccines, and no history of environmental allergies.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Skin test, Urticaria, Urticaria chronic
Clinical narrative: On the onset of the adverse event (1/5/2021) I experienced full body hives and itching. At the same time of the adverse event I was experiencing a miscarriage (blighted ovum). Even after the miscarriage was completed, I continued to experience the persistent hives and itching and was diagnosed with chronic urticaria. Prior to receiving the COVID booster shot, I had never had any allergic reactions to food, vaccines, and no history of environmental allergies.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Administered COVID vaccine past thaw expiration date.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Mobility decreased, Pain in extremity, Pruritus
Clinical narrative: Immediately after receiving 1st dose head above neck area itches. (tongue, scalp, forehead, ears, inside of the mouth area, eyes, and nose) Pain in arm down to elbow and pinky finger. Arm and pink unable to move and lift properly.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive COVID-19
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was accidently given the PfizerPed vaccine instead of the Pfizer for 12 and up. No problems noted after vaccination.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy skin abnormal, Calciphylaxis, Chills, Exposure to SARS-CoV-2, Groin pain
Clinical narrative: 52 y.o. female who presents with fever and chills. Started today, along with nausea, increasing pain in left inguinal area close to where she had a skin biopsy the day before. Skin biopsy shows calciphylaxis. Patient was also exposed to COVID 19 when her husband tested positive last Friday. She denies any respiratory symptoms. No chest pain, no shortness of breath, no diarrhea, no abdominal pain.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: 52 y.o. female who presents with fever and chills. Started today, along with nausea, increasing pain in left inguinal area close to where she had a skin biopsy the day before. Skin biopsy shows calciphylaxis. Patient was also exposed to COVID 19 when her husband tested positive last Friday. She denies any respiratory symptoms. No chest pain, no shortness of breath, no diarrhea, no abdominal pain.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye pruritus, Immediate post-injection reaction, Mobility decreased, Oral pruritus, Pain in extremity
Clinical narrative: Immediately after receiving 1st dose head above neck area itches. (tongue, scalp, forehead, ears, inside of the mouth area, eyes, and nose) Pain in arm down to elbow and pinky finger. Arm and pink unable to move and lift properly.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Tongue pruritus
Clinical narrative: Immediately after receiving 1st dose head above neck area itches. (tongue, scalp, forehead, ears, inside of the mouth area, eyes, and nose) Pain in arm down to elbow and pinky finger. Arm and pink unable to move and lift properly.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive COVID-19
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine was at room temperature for over 24 hours.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Chest X-ray, Chest pain, Computerised tomogram thorax, Condition aggravated
Clinical narrative: Approximately 19-20 hrs. post booster I began with chest pain and palpitations. As the day progressed the chest pain became more intense with radiation to both upper arms and associated SOB, lightheadedness, and nausea. This lasted through out day/night. I awoke from a sound sleep at 5AM 2/6 with severe substernal CP, profound diaphoresis, SOB, nausea and lightheadedness. Temp was 101. Presented to local ER for evaluation. CXR, labs (to include troponin x2), ECG, chest CT were completed. Received IVF bolus. Diagnosis was a reaction to COVID 19 Booster. Discharged to home.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Electrocardiogram, Hyperhidrosis, Nausea
Clinical narrative: Approximately 19-20 hrs. post booster I began with chest pain and palpitations. As the day progressed the chest pain became more intense with radiation to both upper arms and associated SOB, lightheadedness, and nausea. This lasted through out day/night. I awoke from a sound sleep at 5AM 2/6 with severe substernal CP, profound diaphoresis, SOB, nausea and lightheadedness. Temp was 101. Presented to local ER for evaluation. CXR, labs (to include troponin x2), ECG, chest CT were completed. Received IVF bolus. Diagnosis was a reaction to COVID 19 Booster. Discharged to home.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Palpitations, Troponin, Vaccination complication
Clinical narrative: Approximately 19-20 hrs. post booster I began with chest pain and palpitations. As the day progressed the chest pain became more intense with radiation to both upper arms and associated SOB, lightheadedness, and nausea. This lasted through out day/night. I awoke from a sound sleep at 5AM 2/6 with severe substernal CP, profound diaphoresis, SOB, nausea and lightheadedness. Temp was 101. Presented to local ER for evaluation. CXR, labs (to include troponin x2), ECG, chest CT were completed. Received IVF bolus. Diagnosis was a reaction to COVID 19 Booster. Discharged to home.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present, Protein urine present
Clinical narrative: Two days after the first vaccine,  on 1/14/22, patient urinated 3-4 times in the evening and it was bloody in appearance.  He is on a weekly infusion of Casimersen and parent does a weekly UA at home with strips and used those to check his urine at this time and protein was 100 mg/dL.  No pain, fluid retention or any others symptoms noted.  The next morning,  urine appeared normal and protein level back to trace,  which it is on occasion with infusions. There was nothing different in diet or routine, other than vaccine, that could be related and parent has never seen his urine this color or protein this high. His care team was notified and consulted prior to receiving second vaccine on 2/5. They documented findings in his chart but did not report. Once PCP was notified of the reaction on 2/5/22 we asked parent to send a summary of what had occurred to ensure it was reported.  To date,  there have been no issues following second vaccine.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive COVID-19
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Tachycardia
Clinical narrative: Chest tightness with SOB and tachycardia (128bpm) after second dose of Covid-19 vaccine with recent Covid-19 infection of 12/8/21
Age: 99.0
Sex: F
Vaccine: COVID19, COVID19, DTAP
Symptoms: Angiogram normal, Aphasia, Asthenia, Computerised tomogram head normal, Facial paralysis
Clinical narrative: 99 y.o. F w PMH of HTN, IPF with chornic hypoxic resp failure on 1 L NC, obesity, CKD III who lives independatnly presents to ER with facial droop and word finding difficulties. Her symptoms started this afternoon and last known normal was 1500. There was mention of body weakness on ER triage, but her NIH was 1 on arrival. CTOH  were unremarkable, CTA was pending but reportedly normal after Neurology evaluation. ER discussed with Neurology and decision to not pursue tpa. She was given loading doses of aspirin and plavix. She denies any fevers, chills, sob, chest pains, abd pains, rash, weakness, or other symptoms.
Age: 99.0
Sex: F
Vaccine: COVID19, COVID19, DTAP
Symptoms: NIH stroke scale
Clinical narrative: 99 y.o. F w PMH of HTN, IPF with chornic hypoxic resp failure on 1 L NC, obesity, CKD III who lives independatnly presents to ER with facial droop and word finding difficulties. Her symptoms started this afternoon and last known normal was 1500. There was mention of body weakness on ER triage, but her NIH was 1 on arrival. CTOH  were unremarkable, CTA was pending but reportedly normal after Neurology evaluation. ER discussed with Neurology and decision to not pursue tpa. She was given loading doses of aspirin and plavix. She denies any fevers, chills, sob, chest pains, abd pains, rash, weakness, or other symptoms.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: At room temperature over 24 hours.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Joint range of motion decreased, Pain in extremity
Clinical narrative: Limited range of motion, burring in arm, arm soreness
Sex: F
Vaccine: COVID19
Symptoms: Dyspepsia
Clinical narrative: Woman experienced heart burn like pain in her chest.  no shortness of breath
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Positive COVID-19
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 hospitalization
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Cardiac stress test, Chest X-ray, Chest discomfort, Chest pain
Clinical narrative: Within a day developed chest pain, tightness, heaviness, palpitations. Progressed over time. Repeated ER visits. Later diagnosed with Postural Orthostatic Tachycardia Syndrome. Am now completely bedridden.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax, Echocardiogram, Electrocardiogram, Palpitations, Postural orthostatic tachycardia syndrome
Clinical narrative: Within a day developed chest pain, tightness, heaviness, palpitations. Progressed over time. Repeated ER visits. Later diagnosed with Postural Orthostatic Tachycardia Syndrome. Am now completely bedridden.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Fatigue, Multisystem inflammatory syndrome in children, Nausea
Clinical narrative: MIS-C Diagnosis Symptoms- fever, fatigue, cough, nausea, decrease appetite
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: MIS-C Diagnosis Symptoms- fever, fatigue, cough, nausea, decrease appetite
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis
Clinical narrative: A 13-year-old female patient at the end of the immunization began to feel dizzy and sweaty. Following this event, he was sent to the observation and treatment area.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Pain in extremity
Clinical narrative: Approximately 2 - 3 weeks after my booster shot I experienced the following; Abdominal throbbing pain (Lower right part) and some leg pain (both legs). I went to my primary doctor and he prescribed me with gas pills and Fiber that I include in my coffee in the morning. It did help and the pain went away.   As for the leg pain my doctor gave me some physical exercises that seemed to help but as of today it still comes and go every once in a while.
Age: 78.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID-19
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: COVID hospitalization
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID hospitalization
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, Injection site pain, Product administration error, Pyrexia
Clinical narrative: Patient was given a third dose of covid-19 vaccine in error.  His records at our health center did not indicate he was given a second covid-19 vaccine at an outside facility on 1/21/22. The State registry did not show the second vaccine given on 1/21/22 in the system. The guardian with the patient was not aware that patient had received his second dose of covid-19 vaccine while under the care of the other parent who was not present at appointment. He reported fever to 103 and left arm pain on 2/9/22, but is being managed at home with OTC pain relievers and fever reducers.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT WAS GIVEN EXPIRED COVID VACCINATION
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Insomnia, Mobility decreased, Myalgia
Clinical narrative: I took the vaccine booster vaccine on 10/12/2021 and started experiencing discomfort on 10/14/2021 by the morning of 10/17/2021 the pain was severe and unbearable. I contacted Dr. On Demand and prescribed Ibuprofen 800mg, Metoprolol 50mg, Lidocaine 3%, Diclofenac 1% for muscle and joint pain, swelling, limited movement and trouble sleeping.  I called the doctor on 10/29/2021 with same issues but the pain had moved received the same instructions. 11/26/2021 called the doctor for swelling in both hands. Was given prednisone 20mg. 11/29/2021, seen my primary doctor and was told to see an Orthopaedic doctor. I started seeing the Orthopaedic doctor and was prescribed Gabapentin 300mg and Meloxicam 15mg. Since still experience the same pain a MRI is scheduled for 2/11/2022. I was also told contact the CDC back in October but never was able to find the link. I was given the link to on 02/10/2022 to file.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling, Swelling
Clinical narrative: I took the vaccine booster vaccine on 10/12/2021 and started experiencing discomfort on 10/14/2021 by the morning of 10/17/2021 the pain was severe and unbearable. I contacted Dr. On Demand and prescribed Ibuprofen 800mg, Metoprolol 50mg, Lidocaine 3%, Diclofenac 1% for muscle and joint pain, swelling, limited movement and trouble sleeping.  I called the doctor on 10/29/2021 with same issues but the pain had moved received the same instructions. 11/26/2021 called the doctor for swelling in both hands. Was given prednisone 20mg. 11/29/2021, seen my primary doctor and was told to see an Orthopaedic doctor. I started seeing the Orthopaedic doctor and was prescribed Gabapentin 300mg and Meloxicam 15mg. Since still experience the same pain a MRI is scheduled for 2/11/2022. I was also told contact the CDC back in October but never was able to find the link. I was given the link to on 02/10/2022 to file.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Immediate post-injection reaction, Laboratory test, Menstruation irregular, Pruritus
Clinical narrative: Immediately after injection, I had an allergic reaction itchiness in my throat and lymph nodes. The vaccine triggered my period the same day which was weird because my menstrual cycle just ended a week prior. I thought it was just spotting, but when I got home, I had a regular flow like a monthly period. The nurse practitioner there told me to take Benadryl. My roommate got me Benadryl and went to get food and went home. I woke up with intense vertigo for the next couple of days. The room was spinning around me; all the way to Sunday, I had severe vertigo and couldn't go to school all the way until 01/31/2022. I went to class on 02/01/2022. I went to class fine on 02/02/2022, but had a sharp headache after dinner that evening. The vertigo returned the following Thursday, 02/03/2022 and I couldn't go to class that Thursday until this Monday, 02/07/2022. I called my doctor who told the nurse practitioner to do a check-up as they diagnosed me with BPPV (benign paroxysmal positional vertigo). No medication would aid proper treatment to aid my recovery; I was given worksheets to exercise my brain for when experiencing vertigo episodes. I was also suggested to see an acupuncturist to help with treatment.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation, Vertigo, Vertigo positional
Clinical narrative: Immediately after injection, I had an allergic reaction itchiness in my throat and lymph nodes. The vaccine triggered my period the same day which was weird because my menstrual cycle just ended a week prior. I thought it was just spotting, but when I got home, I had a regular flow like a monthly period. The nurse practitioner there told me to take Benadryl. My roommate got me Benadryl and went to get food and went home. I woke up with intense vertigo for the next couple of days. The room was spinning around me; all the way to Sunday, I had severe vertigo and couldn't go to school all the way until 01/31/2022. I went to class on 02/01/2022. I went to class fine on 02/02/2022, but had a sharp headache after dinner that evening. The vertigo returned the following Thursday, 02/03/2022 and I couldn't go to class that Thursday until this Monday, 02/07/2022. I called my doctor who told the nurse practitioner to do a check-up as they diagnosed me with BPPV (benign paroxysmal positional vertigo). No medication would aid proper treatment to aid my recovery; I was given worksheets to exercise my brain for when experiencing vertigo episodes. I was also suggested to see an acupuncturist to help with treatment.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Diffuse migrating urticaria that started about 11 days post Moderna Booster.  It is still present now 3 days later and is minimally responsive to oral antihistamines